Back
Welltower, Inc. 10K Form
Buy
69
WELL
Welltower, Inc.
Last Price:
$203.89
Seasonality Move:
4.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-06 | 10Q | WELL/Welltower, Inc. Quarterly |
| 2020-05-07 | 10Q | WELL/Welltower, Inc. Quarterly |
| 2020-02-14 | 10K | WELL/Welltower, Inc. Annual |
| 2019-10-30 | 10Q | WELL/Welltower, Inc. Quarterly |
| 2019-08-01 | 10Q | WELL/Welltower, Inc. Quarterly |
| 2019-04-30 | 10Q | WELL/Welltower, Inc. Quarterly |
Receive WELL News And Ratings
See the #1 stock for the next 7 days that we like better than WELL
WELL Financial Statistics
Sales & Book Value
| Annual Sales: | $8B |
|---|---|
| Cash Flow: | $730.5M |
| Price / Cash Flow: | 70.79 |
| Annual Sales: | $56.65 |
| Price / Book: | 3.58 |
Profitability
| EPS (TTM): | 1.32690 |
|---|---|
| Net Income (TTM): | $967.8M |
| Gross Margin: | $1.5B |
| Return on Equity: | 2.78% |
| Return on Assets: | 1.8% |
Welltower, Inc. Earnings Forecast
Key Welltower, Inc. Financial Ratios
-
The Gross Profit Margin over the past 42 years for WELL is 19.15%.
-
The Selling, General & Administrative Expenses for WELL have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 61.92% of Operating Income.
-
The Net Earning history of WELL is 12.18% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 17 years.
Welltower, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care REITs |
| Sector: | Real Estate |
| Current Symbol: | WELL |
| CUSIP: | 95040Q |
| Website: | welltower.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 463.49 |
| Quick Ratio: | 266.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 244.96 |
|---|---|
| Forward P/E Ratio: | 70.11 |
WELL Technical Analysis vs Fundamental Analysis
Buy
69
Welltower, Inc. (WELL)
is a Buy
Is Welltower, Inc. a Buy or a Sell?
-
Welltower, Inc. stock is rated a BuyThe current Welltower, Inc. [WELL] share price is $203.87. The Score for WELL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.